IDYA earnings date and last-quarter result: last quarter beat, P/E -22.15. Updated 2026-07-23.
IDEAYA Biosciences (IDYA) Research Hub
IDEAYA Biosciences (IDYA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 32.88 USD (-5.27%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -22.15, market cap 3.36B. This hub links to the full technical, earnings and options research available for IDYA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 32.88 USD (-5.27%) |
| 52-week range | 29.36 USD – 42.68 USD |
| Trend regime | Range |
| 14-day RSI | 32 (Bearish) |
| Trailing P/E | -22.15 |
| Market cap | 3.36B |
| Dividend yield | 0.00% |
Available research for IDYA
Covered Call on IDYA: how it works, illustrative setup around the real 32.88 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IDYA: how it works, illustrative setup around the real 32.88 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IDYA: how it works, illustrative setup around the real 32.88 USD price, max profit/loss, breakeven and when to use it. Educational.
IDYA technical analysis: range, last 32.88 USD, RSI 32, 52w range 29.36 USD–42.68 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IDYA in?
IDEAYA Biosciences (IDYA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IDYA in an uptrend or downtrend?
As of 2026-10-26, IDYA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IDYA's trailing P/E ratio?
IDYA's trailing P/E is -22.15, with a market cap of 3.36B. See the earnings research page for full valuation detail.